Edgewise Therapeutics Inc (EWTX)

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Guided by its holistic drug discovery approach to targeting the muscle as an organ, Edgewise has combined its foundational expertise in muscle biology and small molecule engineering to build its proprietary, muscle focused drug discovery platform. Edgewise’s platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases.

Data as of 2021-07-19 10:20:36 -0400
Market Cap973.265 Million Shares Outstanding49.254 Million Avg 30-day Volume299.392 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-1.03 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low40.49 / 19.64 Next Earnings Date2021-08-16 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 0 4 (0.23%) No data
Funds Holding: 31 0 20 (1.17%) No data
13F shares: 45.232 Million 0 34.729 Million No data
% Ownership No data
New Positions: 30 20 No data
Increased Positions No data
Closed Positions No data
Reduced Positions No data
Total Calls No data
Total Puts No data
PUT/CALL Ratio No data No data
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Edgewise Therapeutics Inc YCharts
Yahoo! Finance finviz

Funds Holding EWTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EWTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DONOVAN JOANNE M. CMO

160,000 2021-04-30 2

FLYNN JAMES E

DEERFIELD MGMT IV, L.P.

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

DEERFIELD PRIVATE DESIGN FUND IV, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
 No longer subject to file 2021-03-30 1

WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P.

  • 10% Owner
 No longer subject to file 2021-03-30 1

NOVO HOLDINGS A/S

  • 10% Owner
 5,587,207 2021-03-30 1

THOMPSON PETER A.

  • Director
  • 10% Owner
 13,679,055 2021-03-30 1

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

ORBIMED GENESIS GP LLC

  • Director
  • 10% Owner
 13,679,055 2021-03-30 1

ROOT JONATHAN D

  • Director
 3,489,168 2021-03-30 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 22:15:03 UTC -4.1236 4.2036 100000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 21:45:03 UTC -4.1236 4.2036 100000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 21:15:03 UTC -4.1236 4.2036 100000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 20:45:03 UTC -3.9072 3.9872 100000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 20:15:05 UTC -3.9072 3.9872 100000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 19:45:03 UTC -3.9072 3.9872 100000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 19:15:03 UTC -3.9072 3.9872 40000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 18:45:03 UTC -3.9072 3.9872 40000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 18:15:03 UTC -3.9072 3.9872 40000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 17:45:03 UTC -3.9072 3.9872 40000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 17:15:02 UTC -3.9072 3.9872 40000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 16:45:02 UTC -3.9072 3.9872 40000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 16:15:03 UTC -3.9072 3.9872 40000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 15:45:02 UTC -3.9072 3.9872 40000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 15:15:03 UTC -3.9072 3.9872 40000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 14:45:03 UTC -3.9072 3.9872 40000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 14:15:03 UTC -3.9072 3.9872 40000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 13:45:03 UTC -3.9072 3.9872 40000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 13:15:03 UTC -3.9072 3.9872 40000
EDGEWISE THERAPEUTICS INC EWTX 2021-07-23 12:45:03 UTC -3.9072 3.9872 40000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Series Portfolios Trust- Weiss Alternative Balanced Risk Fund EWTX -32.0 shares, $-916.48 2021-04-30 N-PORT

Elevate your investments